PMC Articles for MedGen (Select 904175) - PMC

Links from MedGen

Items: 1 to 20 of 349

<< First< Prev

Page of 18

Select item 111889081.

Changes in blood lipid levels and influencing factors among treatment-naïve adult male HIV/AIDS patients following BIC/FTC/TAF vs. 3TC+EFV+TDF

Xi Wang, An Liu, Zaicun Li, Hongwei Zhang, Ruojun Esther Wu, Ying Shao, Jianwei Li, Jiangzhu Ye, Wei Liu, Lijun Sun

Chin Med J (Engl) 2024 Jun 20; 137(12): 1447–1452. Published online 2024 May 30. doi: 10.1097/CM9.0000000000003147

PMCID:: PMC11188908

Abstract Article PDF–836K

Select item 110242932.

Value of carotid corrected flow time or changes value of FTc could be more useful in predicting fluid responsiveness in patients undergoing robot-assisted gynecologic surgery: a prospective observational study

Xixi Tang, Jingqiu Liang, Dongling Tan, Qi Chen, Chengfu Zhou, Tingjun Yang, Hongliang Liu

Front Med (Lausanne) 2024; 11: 1387433. Published online 2024 Apr 4. doi: 10.3389/fmed.2024.1387433

PMCID:: PMC11024293

Abstract Article PDF–890K

Select item 109170783.

Reasons, safety and efficacy analysis for conversion of HAART to TAF/FTC/BIC among HIV-infected patients

Jiang Xiao, Guiju Gao, Yi Ding, Jialu Li, Chengyu Gao, Qiuhua Xu, Liang Wu, Hongyuan Liang, Liang Ni, Fang Wang, Yujiao Duan, Di Yang, Hongxin Zhao

Chin Med J (Engl) 2023 Dec 20; 136(24): 2931–2937. Published online 2023 Nov 29. doi: 10.1097/CM9.0000000000002939

PMCID:: PMC10917078

Abstract Article PDF–537K

Select item 107982794.

A retrospective observation of virologically suppressed people living with HIV by comparing switching to BIC/TAF/FTC with initial use BIC/TAF/FTC

Yuzhi Shi, Xianghua Dai, Li Huang, Jian Xu

Ann Med. 2023; 55(2): 2305692. Published online 2024 Jan 18. doi: 10.1080/07853890.2024.2305692

PMCID:: PMC10798279

Abstract Article PDF–564K

Select item 105826275.

Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women

Kathleen E. Hurwitz, Oluwaseyi O. Isehunwa, Kayla R. Hendrickson, Manjeetha Jaggernath, Yolandie Kriel, Patricia M. Smith, Mxolisi Mathenjwa, Kara Bennett, Christina Psaros, Jared M. Baeten, David R. Bangsberg, Jessica E. Haberer, Jennifer A. Smit, Lynn T. Matthews

Front Reprod Health. 2023; 5: 1263422. Published online 2023 Oct 4. doi: 10.3389/frph.2023.1263422

PMCID:: PMC10582627

Abstract Article PDF–2.2M

Select item 104950636.

Clinical pharmacology of the SingleTablet Regimen (STR) Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF)

Giovanni Di Perri

Infez Med. 2023; 31(3): 283–289. Published online 2023 Sep 1. doi: 10.53854/liim-3103-3

PMCID:: PMC10495063

Abstract Article PDF–569K

Select item 104613287.

Steady-state pharmacokinetics of plasma tenofovir alafenamide (TAF), tenofovir (TFV) and emtricitabine (FTC), and intracellular TFV-diphosphate and FTC-triphosphate in HIV-1 infected old Japanese patients treated with bictegravir/FTC/TAF

Hieu Trung Tran, Kiyoto Tsuchiya, Akira Kawashima, Koji Watanabe, Yoshiharu Hayashi, Shoraku Ryu, Akinobu Hamada, Hiroyuki Gatanaga, Shinichi Oka

Glob Health Med. 2023 Aug 31; 5(4): 216–222. Published online 2023 Aug 31. doi: 10.35772/ghm.2023.01060

PMCID:: PMC10461328

Abstract Article PDF–518K

Select item 99101068.

EVG/COBI/FTC/TAF Bioequivalence Comparing Whole Tablets with Tablets Dissolved in Tap Water

Adriana Andrade, Edward J. Fuchs, Mark A. Marzinke, Sandra Abdul Massih, Jennifer Breakey, Sasha Beselman, Ian McNicholl, Craig W. Hendrix

AIDS Res Hum Retroviruses. January 2023; 39(1): 38–43. Published online 2023 Jan 11. doi: 10.1089/aid.2022.0085

PMCID:: PMC9910106

Abstract Article PDF–556K

Select item 94055139.

Viro-Immunological, Clinical Outcomes and Costs of Switching to BIC/TAF/FTC in a Cohort of People Living with HIV: A 48-Week Prospective Analysis

Maria Mazzitelli, Mattia Trunfio, Cristina Putaggio, Lolita Sasset, Davide Leoni, Sara Lo Menzo, Daniele Mengato, Anna Maria Cattelan

Biomedicines. 2022 Aug; 10(8): 1823. Published online 2022 Jul 28. doi: 10.3390/biomedicines10081823

PMCID:: PMC9405513

Abstract Article PDF–439K

Select item 878935910.

Treatment initiation or switch to BIC/FTC/TAF – real-world safety and efficacy data from two HIV centers in Romania

Oana Săndulescu, Mădălina Irimia, Otilia Elisabeta Benea, Mariana Mărdărescu, Liliana Lucia Preoțescu, Carmen Mihaela Dorobăț, Isabela Ioana Loghin, Irina Cristina Nicolau, Raluca Elena Jipa, Ramona Ștefania Popescu, Cristina Loredana Benea, Alina Cozma, Ioana Andreea Dărămuș, Victor Daniel Miron, Liviu Jany Prisăcariu, Adriana Florina Bahnă, Irina Nistor, Oana Manuela Secrieru, Silvas George, Andreea Bîrcă, Loredana Dobrea, Alexandra-Ștefana Șogorescu, Ioana Viziteu, Anca Streinu-Cercel

Germs. 2021 Dec; 11(4): 512–522. Published online 2021 Dec 29. doi: 10.18683/germs.2021.1286

PMCID:: PMC8789359

Abstract Article PDF–567K

Select item 876429511.

Patient Satisfaction with Once-Daily Single-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (DRV/c/FTC/TAF): A Real-World Study of Patient Self-Reported Outcomes in HIV-1–Diagnosed Adults

Joyce LaMori, Antoine Seignez, Lise Radoszycki

Patient Prefer Adherence. 2022; 16: 83–94. Published online 2022 Jan 13. doi: 10.2147/PPA.S332555

PMCID:: PMC8764295

Abstract Article PDF–3.0M

Select item 862806512.

Outcomes After Switching to BIC/FTC/TAF in Patients with Virological Failure to Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors: A Real-World Cohort Study

Hui-Min Chang, Pei-Yun Chou, Chen-Hsi Chou, Hung-Chin Tsai

Infect Drug Resist. 2021; 14: 4877–4886. Published online 2021 Nov 23. doi: 10.2147/IDR.S331647

PMCID:: PMC8628065

Abstract Article PDF–2.5M

Select item 822074613.

Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study

Andrea Giacomelli, Federico Conti, Laura Pezzati, Letizia Oreni, Anna Lisa Ridolfo, Valentina Morena, Cecilia Bonazzetti, Gabriele Pagani, Tiziana Formenti, Massimo Galli, Stefano Rusconi

BMC Infect Dis. 2021; 21: 595. Published online 2021 Jun 22. doi: 10.1186/s12879-021-06304-3

PMCID:: PMC8220746

Abstract Article PDF–720K

Select item 820876914.

Retraction notice for: “lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line” [Braz J Med Biol Res (2018) 51(6): e7046]

Braz J Med Biol Res. 2021; 54(6): e7046retraction. Published online 2021 Jun 14. doi: 10.1590/1414-431X2020e7046retraction

Retracts:: Braz J Med Biol Res. 2018; 51(6): e7046.

PMCID:: PMC8208769

Retraction PDF–2.4M

Select item 813479615.

Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature

L. Samuel Hellgren, Martin Hysek, Kenbugul Jatta, Jan Zedenius, C. Christofer Juhlin

Head Neck Pathol. 2021 Jun; 15(2): 668–675. Published online 2020 Jul 25. doi: 10.1007/s12105-020-01208-1

PMCID:: PMC8134796

Abstract Article PDF–1.2M

Select item 775047516.

Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells

Marie-Pierre Courageot, Laurent Duca, Laurent Martiny, Emmanuelle Devarenne-Charpentier, Hamid Morjani, Hassan El Btaouri

Front Oncol. 2020; 10: 551228. Published online 2020 Dec 7. doi: 10.3389/fonc.2020.551228

PMCID:: PMC7750475

Abstract Article PDF–2.2M

Select item 770780317.

FAM172A promotes follicular thyroid carcinogenesis and may be a marker of FTC

Pei-Pei Xu, Su Zeng, Xiao-Tian Xia, Zi-Heng Ye, Mei-Fang Li, Ming-Yun Chen, Tian Xia, Jing-Jing Xu, Qiong Jiao, Liang Liu, Lian-Xi Li, Ming-Gao Guo

Endocr Relat Cancer. 2020 Nov; 27(11): 657–669. Published online 2020 Sep 21. doi: 10.1530/ERC-20-0181

PMCID:: PMC7707803

Abstract Article PDF–2.8M

Select item 754916018.

Erratum to “Thyroid Tumor: Investigating MicroRNA-21 Gene Suppression in FTC and FTA”

Cancer Inform. 2020; 19: 1176935120968515. Published online 2020 Oct 10. doi: 10.1177/1176935120968515

Corrects:: Cancer Inform. 2020; 19: 1176935120948474.

PMCID:: PMC7549160

Correction PDF–371K

Select item 747575019.

An Analysis of the FTC’s Attempt to Stop the Altria-Juul Labs Deal

David T. Levy, Clifford E. Douglas, Luz Maria Sanchez-Romero, K. Michael Cummings, David T. Sweanor

Tob Regul Sci. Author manuscript; available in PMC 2020 Sep 7.

Published in final edited form as: Tob Regul Sci. 2020 Jul; 6(4): 302–305. doi: 10.18001/TRS.6.4.7

PMCID:: PMC7475750

Abstract Article PDF–42K

Select item 747046620.

Short-term Adverse Events With BIC/FTC/TAF: Postmarketing Study

Edwin Hayes, Caroline Derrick, Danielle Smalls, Hilary Smith, Nicole Kremer, Sharon Weissman

Open Forum Infect Dis. 2020 Sep; 7(9): ofaa285. Published online 2020 Sep 3. doi: 10.1093/ofid/ofaa285

PMCID:: PMC7470466

Abstract Article PDF–251K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 349

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity